Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SRKP 6 INC | 184,981 | reported | 04 Apr 2011 | tx 15+484,981 |
| ARADIGM CORP | 97,323 | reported | 29 Jun 2018 | tx 6+688,689 |
| SUPERNUS PHARMACEUTICALS, INC. | 60,413 | reported | 12 Mar 2026 | tx 49+253,292−113,324 |
| scPharmaceuticals Inc. | 0 | reported | 07 Oct 2025 | tx 12+124,146−72,174 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 50.61 USD | |
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 2,989 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,977 | 0.00 USD | deriv |
| 09 Jan 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 12.98 USD | |
| 09 Jan 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 19,750 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 16,300 | 0.00 USD | deriv |
| 07 Oct 2025 | OTHER | scPharmaceuticals Inc. | 6,124 | 0.00 USD | deriv |
| 14 Aug 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 7,457 | 42.26 USD | |
| 03 Jun 2025 | GRANT_AWARD | scPharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 22 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | |
| 22 Feb 2025 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 7,296 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | deriv |
| 22 Jan 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 20,000 | 9.13 USD | |
| 22 Jan 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 20,000 | 0.00 USD | deriv |
| 08 Nov 2024 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 8,722 | 36.28 USD | |
| 11 Jun 2024 | GRANT_AWARD | scPharmaceuticals Inc. | 19,750 | 0.00 USD | deriv |
| 23 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 3,886 | 0.00 USD | |
| 23 Feb 2024 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 3,886 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 8,252 | 0.00 USD | deriv |